MSD publishes its 2019-2020 CSR report


MSD publishes its 2019-2020 CSR report

The report reflects the company’s belief that serving social good and business success are deeply intertwined concepts.

BY RRHHDigital, 14:45 – 01 November 2020

MSD has released its 2019-2020 Corporate Responsibility Report. The report highlights the company’s commitment and progress in its four priority areas of CSR: access to health, employee care, environmental and ethical sustainability and transparency. “The multiple challenges we face in 2020 reinforce more than ever the importance of acting responsibly, following our mission to save and improve lives and deliver lasting value to our business and society” said Ken Frazier, President and CEO of MSD Worldwide. “At MSD, we take our responsibility to be an active agent of well-being in the world, not only through our medicines and vaccines, but also through general actions to fight systemic inequalities and create an environment in which all people are appreciated and respected ”.

The report reflects the company’s belief that serving social good and business success are deeply intertwined concepts.

For the second year, MSD also released an independent report on environment, society and governance, detailing progress towards the Global Reporting Initiative and the Sustainability Accounting Standards Board. The Company has also incorporated a section on the New Corporate Health Culture Framework (COH4B) focused on managing the impact on the health of employees, their families and the communities in which they live.

In line with MSD’s interest in addressing health inequalities, diversity and inclusion, some highlights from this year’s report include:

As of July 2018, the company has donated and shipped over 250,000 doses of its bullet vaccine, (at the time under investigation, but currently approved), to the World Health Organization (WHO) to support efforts to respond to the gunshot epidemic in the Democratic Republic of Congo (DRC). MSD is committed to continuing to provide the doses needed to support the response to the ongoing outbreaks in the Democratic Republic of Congo and neighboring countries. Thanks to the MECTIZAN donation program, in 2019, 344 million treatments were sent to endemic countries for the elimination of river blindness and lymphatic filariasis. MSD for Mothers, our $ 500 million initiative to help create a world where no woman should die in childbirth, has reached over 11 million women in 48 countries. In the United States, the Safer Cities for Childbirth initiative offers solutions to address racial disparities in maternal health in 10 cities and plans to expand to 10 more by 2020. In 2019, 14,400 MSD employees performed a total of 136,000 hours of voluntary work during working hours. As an extension of our commitment to diversity and inclusion, 46% of the company’s executive committee worldwide is made up of women. The company signed the “Valuable 500” initiative to promote a safe workplace for people with disabilities. In 2019, total diversity spend saw an 11% increase in our total spend on acquisitions from minority-owned businesses, women, seniors, LGTB groups and people with disabilities, exceeding so our corporate goal to allocate $ 2,000 million to this concept. Supporting diverse vendors has a positive impact on the communities in which we live and work.

All information on MSD’s approach to corporate responsibility and the progress of its initiatives, in the 2019/2020 corporate responsibility report, on the website

* If you found this article interesting, we encourage you to follow us on TWITTER and subscribe to our DAILY NEWSLETTER.



Back to top button